期刊文献+

改良保留灌肠法对溃疡性结肠炎患者疗效的研究 被引量:17

Study on the effectiveness of improved retention enema for patients with ulcerative colitis
暂未订购
导出
摘要 目的探讨应用保留灌肠治疗溃疡性结肠炎更好的方法。方法选择2010年12月~2011年12月住院符合条件的溃疡性结肠炎患者200例,随机分为观察组与对照组各100例。两组均采用相同的药物治疗,保留灌肠14d。观察组采用改良保留灌肠法,对照组采用传统保留灌肠法。结果观察组和对照组的灌肠药物保留时间分别为(7.02±1.89)h和(5.23±2.11)h,差异有显著意义(P<0.05);两组患者灌肠后腹泻、腹痛、脓血便、血沉和C反应蛋白均较之前好转(P<0.05);灌肠后观察组腹痛、腹泻、脓血便症状和C反应蛋白积分较对照组减轻,差异有显著意义(P<0.05),两组患者灌肠后的血沉积分差异无显著意义(P>0.05)。结论改良保留灌肠法操作方便,能尽可能避免因保留灌肠前肠道清洁准备不足而导致的疗效差异,改善患者症状,值得临床推广应用。 Objective To study a practical and effective improved retention enema method for clinical treatment of ulcerative colitis. Method 200 patients with ulcerative colitis in our hospital from December 2010 to December 2011 were randomly divided into observation group and control group. The two groups were using the same drug treat- ment, retention enema for 14 days. The observation group was treated with improved retention enema, while the control group used the traditional retention enema. Result The drug retention time of the observation group (7.02 ± 1.89)h was significantly higher than that of control group (5.23±2.11) h (P〈0.05). The symptoms such as diarrhea, abdominal pain, bloody stool, ESR and creative protein in two groups were improved than before (P〈 0.05). After retention enema, the scores of diarrhea, abdominal pain, bloody stool and CRP were significantly different between two groups(P〈 0.05); though no statistic difference was found in ESR. Conclusion The improved retention enema was convenient in operating and avoiding the differences in efficacy because of the unsuitable intestinal preparation . It was so effective in improving patients' symptoms and signs. It's worthy of clinical application.
出处 《护士进修杂志》 2012年第16期1501-1503,共3页 Journal of Nurses Training
基金 上海交通大学医学院院内立项课题(编号:Jyh1104)
关键词 改良保留灌肠 溃疡性结肠炎 护理 Improved retention enema Ulcerative colitis Nursing
  • 相关文献

参考文献4

二级参考文献14

  • 1李翠娥,柯娟,符湘云,赵艳梅.灌肠法的现状与进展[J].护士进修杂志,2005,20(3):218-220. 被引量:17
  • 2詹继红,毕莲,丘艳红,彭亚梅.中西医结合治疗慢性肾功能不全21例[J].贵阳中医学院学报,2005,27(3):17-18. 被引量:1
  • 3陈灏珠.实用内科学[M](第11版)[M].北京:人民卫生出版社,2002.1971-1973.
  • 4Sartor RB. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis [J]. Nat Clin Pratt Gastroenterol Hepatol, 2006, 3 (7): 390 -407.
  • 5Caprilli R, Viscido A, Latella G. Current management of severe ulcerative colitis[J]. Nat Clin Pract Gastroenterol Hepatol,2007,4(2):92-101.
  • 6Vermeire S, Van Assche G, Rutgeers P.The role of C-reactive protein as an infalmmatroy marker in gastrointestinal diseases[J]. Nat Clin Pract Gastroenterol Hepatol, 2005,2 ( 12 ) : 580 - 586.
  • 7Vermeire S, Van Assche G, Rutgeers P. C-reactive protein as an marker for inflammatory bowel disease[J]. Inflam Bowel Dis,2004,10(5) :661-665.
  • 8Poullis AP, Zar S, Sundaram KK, etal. A new highly sensitive assay for Creactive protein can aid the differentiation of inflammatory bowel disorders from constipation and diarrhea-predominant functional bowel disorders[ J]. Eur J Gastroenterol Hepatol, 2002,14 (4) : 409-412.
  • 9Rodgers AD, Cummins AG. CliP correlates with clinical score in ulceratvie colitis but not in Crohn's disease[ J]. Dig Dis Sci, 2007, 52(9) : 2063 -2067.
  • 10Solem CA, Loftus EV,Jr Tremains WJ, et al. Correlation of C-reactive protein with clinical, endoscopic, histologic and radiographic activity in intlammatory bowel disease[ J ]. Intlam Bowel Dis,2005,11 (8) : 707-712.

共引文献28

同被引文献146

引证文献17

二级引证文献157

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部